Table 3.
Care Utilization and Mortality Outcomes Among Those With COVID-19 Diagnosed While Hospitalized and RPM-enrolled Upon Discharge to Homea,b
| Outcomesc | Non-Engaged (n=240) | Engaged (n=254) | OR (95% CI) | P |
|---|---|---|---|---|
| ED visits | ||||
| ≥1 ED visit (unique patients) | 37 (15.4) | 37 (14.6) | 0.94 (0.57-1.53) | .79 |
| >1 ED visit (unique patients) | 10 (4.2) | 9 (3.5) | 0.84 (0.34-2.12) | .72 |
| ED visit converted to inpatient hospitalization | 39 (16.3) | 40 (15.8) | 0.96 (0.60-1.56) | .88 |
| Hospital admissions | ||||
| ≥1 Admission (unique patients) | 51 (21.3) | 40 (15.8) | 0.69 (0.44-1.09) | .12 |
| >1 Admission (unique patients) | 10 (4.2) | 10 (4.0) | 0.94 (0.39-2.31) | .90 |
| Prolonged hospitalization (7 or more days) | 23 (9.6) | 9 (3.5) | 0.35 (0.16-0.77) | .01 |
| ICU admissions | 14 (5.8) | 8 (3.2) | 0.52 (0.22-1.28) | .16 |
| Mortality (30 day) | 5 (2.1) | 2 (0.8) | 0.37 (0.07-1.94) | .24 |
| Mean difference (95% CI) | ||||
|---|---|---|---|---|
| Average length of stayd | ||||
| Mean (SD) | 7.5 (7.0) | 4.8 (3.5) | -2.7 (-5.1 to -0.3) | .03 |
| Median (range) | 6 (1-30) | 4 (1-18) | ||
| Total hospital daysd | ||||
| Total | 450 | 262 | ||
| Mean (SD) | 8.8 (7.8) | 6.6 (6.4) | -2.3 (-5.3 to 0.8) | .14 |
| Median (range) | 7 (1-30) | 5 (1-28) | ||
| Total ICU dayse | ||||
| Total | 68 | 27 | ||
| Mean (SD) | 4.9 (5.7) | 3.4 (3.3) | -1.5 (-6.1 to 3.1) | .51 |
| Median (range) | 3 (1-19) | 2 (1-10) |
a
COVID-19, coronavirus disease 2019; ED, emergency department; ICU, intensive care unit; OR, odds ratio; RPM, remote patient monitoring.
b
Values shown are n (%) unless otherwise stated.
c
All data are reported for events that occurred within 30 days of RPM program enrollment for outpatient diagnosis or 30 days from discharge of a hospitalized patient.
d
Data reported for those patients who had a hospital admission.
e
Data reported for those patients who had an ICU admission.